According to FutureWise analysis, the Pharmaceutical Spray Drying Market in 2025 is US$2.32 billion and is expected to reach US$4.51 billion by 2033, at a CAGR of 8.66%. The pharmaceutical spray drying market is experiencing growth due to several key factors. There is an increasing demand for inhalable drugs, a rising adoption of advanced drug delivery systems, and the expansion of the biopharmaceutical sector. Additionally, the trend toward personalized medicine and the development of high-value biologics are further enhancing market demand. Emerging economies are witnessing significant investments in pharmaceutical manufacturing, which contributes to the overall expansion of the market. The pharmaceutical spray drying market is expanding due to its growing use in improving the solubility and bioavailability of poorly water-soluble drugs. The increasing demand for controlled-release formulations and inhalable drug delivery systems is also driving adoption. Furthermore, advancements in spray drying technologies and the rise of contract manufacturing organizations (CMOs) are contributing to the market's growth.

Integration of Artificial Intelligence (AI): AI is transforming the pharmaceutical spray drying industry by improving process optimization and formulation development. AI algorithms help predict the best spray drying conditions, enhance product consistency, and accelerate the development of complex formulations, including biologics and mRNA-based therapies.

Bullock and colleagues conducted the initial research into the application of spray drying in pharmaceuticals in the 1940s and used it to infusions, extracts, inorganic medicinal salts, adrenaline, and vitamin C. The creation of pharmaceutical excipients and the isolation of active components that were either thermally sensitive or challenging to crystallize were two of the many other applications that came after. Contrary to popular belief, spray drying is a relatively gentle drying procedure because, first the materials are only briefly exposed to heat (a few seconds at most), and second the materials are shielded from higher bulk temperatures by the cooling action of the evaporation process. Despite its many applications, it wasn't until the turn of the century that spray drying's use in pharmaceutical applications saw a noticeable rise.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Pharmaceutical Spray Drying Market trends that shall affect the overall market growth.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=10976&type=requestsample

By Product Type

• Rotary Atomizer
• Nozzle Atomizer
• Fluidized
• Centrifugal

By Application

• Excipient Production
• Encapsulation
• Enhancing Bioavailability
• Dry Powder Inhalers
• Others
• Wholesale

• • Retail (in-store)
  • Distributors/ Franchises

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Pharmaceutical Spray Drying Market:

• Albany Molecular Research Inc.
• Catalent, Inc
• Thermo Fisher Scientific Inc.
• Hovione
• Fuji Chemical Industry Co., Ltd
• Nova Laboratories
• Janssen Global Services, LLC
• Zambon Company S.P.A.
• GlaxoSmithKline plc.
• Novartis AG
• Wuxi AppTec.

Recent developments by key players in the Pharmaceutical Spray Drying Market:

Catalent, Inc.

• Expansion of Spray Drying Capacity: In 2024, Catalent upgraded its large-scale spray drying capabilities at its Boston facility by implementing an advanced spray drying system. This enhancement allows for improved support during late-stage clinical trials and the commercialization of amorphous solid dispersion (ASD) formulations.
• Addition of Inhaled Dry Powder Capabilities: Catalent has enhanced its capabilities for inhaled dry powders by incorporating potent capsule filling. This positions the company as a leading CDMO with substantial GMP capacity for both capsule spray-dried and carrier-based inhaled powders.

Wuxi AppTec.

• In July 2025, WuXi STA launched a new PSD-4 spray dryer at its Taixing API manufacturing facility in China, enhancing its spray-dried dispersion capabilities to support solid-dosage development and improve API solubility and formulation performance.
• In April 2025, both the Changzhou and Taixing API sites successfully passed FDA inspections, reinforcing confidence in their global GMP compliance for spray drying and related drug substance manufacturing.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=10976&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Pharmaceutical Spray Drying Market By Product Type, By Application and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com